(Q36223776)

12 August 2017

1 reference

title

Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. (English)

1 reference

12 August 2017

Matthias Stoll

1

1 reference

PubMed ID

16091232

12 August 2017

Reinhold E Schmidt

series ordinal

2

1 reference

12 August 2017

1 September 2004

1 reference

12 August 2017

Current HIV/AIDS reports

1 reference

12 August 2017

1

1 reference

12 August 2017

3

1 reference

12 August 2017

122-127

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-004-0018-7

12 August 2017

0 references

cites work

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11904-004-0018-7

Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11904-004-0018-7

Immune Restoration Syndrome Manifested by Pulmonary Sarcoidosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11904-004-0018-7

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

21 January 2018

1 reference

12 December 2020

Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy

1 reference

12 December 2020

Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy

1 reference

12 December 2020

Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection

1 reference

12 December 2020

Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

1 reference

12 December 2020

An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Association between Kaposi's sarcoma and atherosclerosis: implications for gammaherpesviruses and vascular disease

1 reference

12 December 2020

Further observations on tuberculin reactions in active tuberculosis

1 reference

12 December 2020

Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person

1 reference

12 December 2020

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

12 December 2020

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

12 December 2020

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia.

1 reference

12 December 2020

Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome.

1 reference

12 December 2020

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

A case of immune reconstitution rheumatoid arthritis

1 reference

12 December 2020

Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.

1 reference

12 December 2020

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

12 December 2020

Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV

1 reference

12 December 2020

An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS

1 reference

12 December 2020

Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection

1 reference

12 December 2020

Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV.

1 reference

12 December 2020

Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy

1 reference

12 December 2020

Dexamethasone in adults with bacterial meningitis

1 reference

12 December 2020

Bacillary splenitis (Bartonella henselae) during immune restoration in an HIV-infected patient

1 reference

12 December 2020

Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature

1 reference

12 December 2020

Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

1 reference

12 December 2020

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy

1 reference

12 December 2020

Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients

1 reference

12 December 2020

Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease.

1 reference

12 December 2020

Cerebral tuberculomas developing during treatment of tuberculous meningitis.

1 reference

12 December 2020

Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy

1 reference

12 December 2020

Highly active antiretroviral therapy

1 reference

12 December 2020

Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy

1 reference

12 December 2020

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy

1 reference

12 December 2020

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

12 December 2020

Immunorestitution disease involving the innate and adaptive response

1 reference

12 December 2020

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

1 reference

12 December 2020

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART

1 reference

12 December 2020

The immune reconstitution inflammatory syndrome

1 reference

12 December 2020

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

12 December 2020

Cytomegalovirus (CMV) Retinitis Immune Restoration Disease Occurs during Highly Active Antiretroviral Therapy–Induced Restoration of CMV‐Specific Immune Responses within a Predominant Th2 Cytokine Environment

1 reference

12 December 2020

Alopecia universalis and Graves’ disease in the setting of immune restoration after highly active antiretroviral therapy

1 reference

12 December 2020

Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy

1 reference

12 December 2020

Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy

1 reference

12 December 2020

10.1007/S11904-004-0018-7

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16091232